Shake it!!!
BIOLOGIX has a total issued and outstanding of approximately 16 million shares distributed amongst approximately 1500 shareholders, 95% of which are U.S. citizens, invested at an average share price of $ 1.50 per share. Officers, directors and insiders hold approximately 57% of the issued and outstanding shares. The public float is approximately 2,000,000 shares; of which an estimated 300,000 are actively traded. BIOLOGIX will continue to trade its stock under the stock symbol: BGIX.
The EPOC System (TM)
THE "EMERGENCY POINT-OF-CARE" LAB IN THE PALM OF YOUR HAND
WORLDWIDE MARKET POTENTIAL
Total Charges for In-Vitro Diagnostic Testing $ 30.0 billion
Cost of In-Vitro Devices & Supplies $ 14.0 billion
Charges for Personnel & All Other Costs $ 16.0 billion
BioLogix Technology Can Address: 65% of Devices / Supplies Market $ 9.1 billion
COMPETITION
i-STAT Corporation, Princeton, New Jersey, NASDAQ-OTC
Trading Symbol: STAT - OTC
Diametrics, Minneapolis, Minnesota, NASDAQ-OTC
Trading Symbol: DMED - OTC
Hem02stat (TM)
THE UNIVERSAL SUBSTITUTE FOR RED BLOOD CELLS AND DELIVERY OF OXYGEN
THIRD GENERATION ARTIFICAL RED BLOOD CELL
CLINICAL DATA ON OVER 3000 PATIENTS TO DATE
PRIOR FDA APPROVAL FOR USE IN SURGERY
$ 10 BILLION WORLDWIDE MARKET
OVER 100 MEDICAL APPLICATIONS
NO TYPE OR CROSS-MATCH REQUIRED
NO REFRIGERATION REQUIRED
INFINITE SHELF-LIFE CONTAMINATION FREE
COMPETITION
Alliance Pharmaceutical Corporation, San Diego, California (NASDAQ - ALLP)
Somatogen Corporation, Boulder, Colorado
BioTime Corporation, Berkley, CA (NASDAQ - BTIM)
|
